Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
have recently explored the molecular mechanism through which CSE triggers eryptosis
No existen restricciones para su consumo durante el embarazo y la lactancia, ya que esta es una sustancia natural, cuya demanda se incrementa durante el embarazo y adems, forma parte de la leche humana
G.WeissmanD.et al
Nuclear IGF-IR regulates gene expression While IGF-IR is usually localized at the plasma membrane in normal cells, it often translocates into the cytoplasm and nucleus in cancer cells even though it does not have the nuclear localization signal [78,79,80]